Loong H - Search Results

1

Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).

Peng W, Cao L, Chen L, Lin G, Zhu B, Hu X, Lin Y, Zhang S, Jiang M, Wang J, Li J, Li C, Shao L, Du H, Hou T, Chen Z, Xiang J, Pu X, Li J, Xu F, Loong H, Wu L. Peng W, et al. Among authors: loong h. Oncologist. 2022 Mar 4;27(2):e116-e125. doi: 10.1093/oncolo/oyab044. Oncologist. 2022. PMID: 35641209 Free PMC article.

2

Multinational Analysis of Estimated Health Care Costs Related to Extended-Interval Fixed Dosing of Checkpoint Inhibitors.

Goldstein DA, Ginsberg GM, Hofnung-Gabbay D, De Abreu Lourenco R, Loong HH, Goh BC, Chan KKW, Di Maio M, Perrone F, Hall PS, Zer A, Rosenbaum E. Goldstein DA, et al. Among authors: loong hh. JAMA Netw Open. 2023 Feb 1;6(2):e230490. doi: 10.1001/jamanetworkopen.2023.0490. JAMA Netw Open. 2023. PMID: 36821111 Free PMC article.

3

Global Health System Resilience during Encounters with Stressors - Lessons Learnt from Cancer Services during the COVID-19 Pandemic.

Yeoh K, Wu Y, Chakraborty S, Elhusseiny G, Gondhowiardjo S, Joseph N, Lee AWM, Loong HH, Msadabwe-Chikuni SC, Tan BF, Ospina AV, Roques T, Shum HM, Yeoh EK. Yeoh K, et al. Among authors: loong hh. Clin Oncol (R Coll Radiol). 2023 Apr;35(4):e289-e300. doi: 10.1016/j.clon.2023.01.004. Epub 2023 Jan 17. Clin Oncol (R Coll Radiol). 2023. PMID: 36764875 Free PMC article.

4

KRAS G12C mutations in Asia: a landscape analysis of 11,951 Chinese tumor samples.

Loong HH, Du N, Cheng C, Lin H, Guo J, Lin G, Li M, Jiang T, Shi Z, Cui Y, Jin X, Yao J, Xing Y, Yao M, Wang K, Mok TSK, Liu L. Loong HH, et al. Transl Lung Cancer Res. 2020 Oct;9(5):1759-1769. doi: 10.21037/tlcr-20-455. Transl Lung Cancer Res. 2020. PMID: 33209599 Free PMC article.

5

Lung cancer: dropping bars or rising hoops--phase III outcomes of NSCLC.

Loong HH, Mok TS. Loong HH, et al. Nat Rev Clin Oncol. 2014 Jul;11(7):381-2. doi: 10.1038/nrclinonc.2014.91. Epub 2014 May 20. Nat Rev Clin Oncol. 2014. PMID: 24840075

6

Clinical Application of Genomic Profiling With Circulating Tumor DNA for Management of Advanced Non-Small-cell Lung Cancer in Asia.

Loong HH, Raymond VM, Shiotsu Y, Chua DTT, Teo PML, Yung T, Skrzypczak S, Lanman RB, Mok TSK. Loong HH, et al. Clin Lung Cancer. 2018 Sep;19(5):e601-e608. doi: 10.1016/j.cllc.2018.04.022. Epub 2018 May 7. Clin Lung Cancer. 2018. PMID: 29807856

7

Therapeutic Strategies in EGFR Mutant Non-Small Cell Lung Cancer.

Loong HH, Kwan SS, Mok TS, Lau YM. Loong HH, et al. Curr Treat Options Oncol. 2018 Sep 29;19(11):58. doi: 10.1007/s11864-018-0570-9. Curr Treat Options Oncol. 2018. PMID: 30267319 Review.

8

Crizotinib in the management of advanced-stage non-small-cell lung cancer.

Loong HH, Mok K, Leung LK, Mok TS. Loong HH, et al. Future Oncol. 2015;11(5):735-45. doi: 10.2217/fon.14.314. Future Oncol. 2015. PMID: 25757678 Review.

9

Overview of current systemic management of EGFR-mutant NSCLC.

Hsu WH, Yang JC, Mok TS, Loong HH. Hsu WH, et al. Among authors: loong hh. Ann Oncol. 2018 Jan 1;29(suppl_1):i3-i9. doi: 10.1093/annonc/mdx702. Ann Oncol. 2018. PMID: 29462253 Free article. Review.

10

Personalized medicine for non-small-cell lung cancer.

Mok TS, Zhou Q, Leung L, Loong HH. Mok TS, et al. Among authors: loong hh. Expert Rev Anticancer Ther. 2010 Oct;10(10):1601-11. doi: 10.1586/era.10.76. Expert Rev Anticancer Ther. 2010. PMID: 20942631 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters